Charles Large is the Chief Executive Officer at Autifony Therapeutics Limited. Specialties: Neuroscience, Electrophysiology, Psychiatric disorders, Epilepsy, Transcranial Magnetic Stimulation, Ion Channels, Lamotrigine, Drug Discovery. Autifony Therapeutics aims to develop new drugs to treat serious disorders of the central nervous system using pioneering science.